| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.21e-20 | 46 | 27 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 4.39e-16 | 188 | 27 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 EIF3A COL11A1 COL22A1 COL11A2 COL1A1 | 5.42e-10 | 891 | 27 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 3.77e-04 | 105 | 27 | 3 | GO:0004867 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.80e-03 | 180 | 27 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.00e-03 | 187 | 27 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | heparin binding | 2.16e-03 | 192 | 27 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 2.46e-03 | 201 | 27 | 3 | GO:0061135 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL23A1 COL5A2 COL18A1 PAPLN COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 ABL1 COL1A1 | 3.98e-13 | 377 | 26 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL23A1 COL5A2 COL18A1 PAPLN COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 ABL1 COL1A1 | 4.09e-13 | 378 | 26 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL23A1 COL5A2 COL18A1 PAPLN COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 ABL1 COL1A1 | 4.21e-13 | 379 | 26 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.68e-08 | 76 | 26 | 5 | GO:0030199 | |
| GeneOntologyCellularComponent | collagen trimer | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 C1QTNF7 SFTPA2 SFTPD COL1A1 | 9.87e-25 | 88 | 27 | 13 | GO:0005581 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 SFTPA2 SFTPD COL1A1 | 2.24e-14 | 530 | 27 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 SFTPA2 SFTPD COL1A1 | 3.41e-13 | 656 | 27 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 SFTPA2 SFTPD COL1A1 | 3.54e-13 | 658 | 27 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.92e-12 | 332 | 27 | 10 | GO:0005788 |
| GeneOntologyCellularComponent | complex of collagen trimers | 4.87e-11 | 21 | 27 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.08e-09 | 12 | 27 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.08e-09 | 12 | 27 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.92e-08 | 5 | 27 | 3 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane | 1.75e-05 | 122 | 27 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.38e-03 | 1179 | 27 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.50e-03 | 1187 | 27 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | multivesicular body | 5.74e-03 | 88 | 27 | 2 | GO:0005771 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 7.50e-03 | 101 | 27 | 2 | GO:0045334 | |
| GeneOntologyCellularComponent | coated vesicle | 1.09e-02 | 360 | 27 | 3 | GO:0030135 | |
| HumanPheno | Vitreoretinopathy | 1.26e-07 | 22 | 12 | 4 | HP:0007773 | |
| HumanPheno | Osteoarthritis | 2.14e-07 | 65 | 12 | 5 | HP:0002758 | |
| HumanPheno | Atrophic scars | 1.12e-06 | 37 | 12 | 4 | HP:0001075 | |
| HumanPheno | Cigarette-paper scars | 1.19e-06 | 10 | 12 | 3 | HP:0001073 | |
| HumanPheno | Abnormal vitreous humor morphology | 3.54e-06 | 49 | 12 | 4 | HP:0004327 | |
| HumanPheno | Abnormal joint physiology | CACNA1A COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL11A2 ABL1 NSUN2 COL1A1 | 4.26e-06 | 1358 | 12 | 11 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | CACNA1A COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL11A2 ABL1 NSUN2 COL1A1 | 4.26e-06 | 1358 | 12 | 11 | HP:0011729 |
| HumanPheno | Joint hypermobility | 6.46e-06 | 557 | 12 | 8 | HP:0001382 | |
| HumanPheno | Limb pain | 6.53e-06 | 57 | 12 | 4 | HP:0009763 | |
| HumanPheno | Subcutaneous spheroids | 1.52e-05 | 3 | 12 | 2 | HP:0025014 | |
| HumanPheno | Atypical scarring of skin | 1.86e-05 | 74 | 12 | 4 | HP:0000987 | |
| HumanPheno | Cervical insufficiency | 3.04e-05 | 4 | 12 | 2 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 3.04e-05 | 4 | 12 | 2 | HP:0025509 | |
| HumanPheno | Incisional hernia | 3.04e-05 | 4 | 12 | 2 | HP:0004872 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 4.81e-05 | 94 | 12 | 4 | HP:0006500 | |
| HumanPheno | High myopia | 4.81e-05 | 94 | 12 | 4 | HP:0011003 | |
| HumanPheno | Foot joint contracture | 5.01e-05 | 334 | 12 | 6 | HP:0008366 | |
| HumanPheno | Degenerative vitreoretinopathy | 5.07e-05 | 5 | 12 | 2 | HP:0007964 | |
| HumanPheno | Bell-shaped thorax | 5.24e-05 | 33 | 12 | 3 | HP:0001591 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 5.75e-05 | 201 | 12 | 5 | HP:0008065 | |
| HumanPheno | Wide anterior fontanel | 5.90e-05 | 99 | 12 | 4 | HP:0000260 | |
| HumanPheno | Scarring | 6.63e-05 | 102 | 12 | 4 | HP:0100699 | |
| HumanPheno | Acrocyanosis | 6.83e-05 | 36 | 12 | 3 | HP:0001063 | |
| HumanPheno | Fragile skin | 7.42e-05 | 37 | 12 | 3 | HP:0001030 | |
| HumanPheno | Dermal atrophy | 8.00e-05 | 107 | 12 | 4 | HP:0004334 | |
| HumanPheno | Abnormal tibia morphology | 8.00e-05 | 107 | 12 | 4 | HP:0002992 | |
| HumanPheno | Peripheral cyanosis | 8.05e-05 | 38 | 12 | 3 | HP:0034033 | |
| HumanPheno | Pulp calcification | 1.06e-04 | 7 | 12 | 2 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 1.06e-04 | 7 | 12 | 2 | HP:0006243 | |
| HumanPheno | Molluscoid pseudotumors | 1.06e-04 | 7 | 12 | 2 | HP:0000993 | |
| HumanPheno | Dumbbell-shaped long bone | 1.06e-04 | 7 | 12 | 2 | HP:0000947 | |
| HumanPheno | Angle closure glaucoma | 1.06e-04 | 7 | 12 | 2 | HP:0012109 | |
| HumanPheno | Uterine prolapse | 1.06e-04 | 7 | 12 | 2 | HP:0000139 | |
| HumanPheno | Flexion contracture | 1.15e-04 | 817 | 12 | 8 | HP:0001371 | |
| HumanPheno | Retinal detachment | 1.17e-04 | 118 | 12 | 4 | HP:0000541 | |
| HumanPheno | Soft skin | 1.25e-04 | 44 | 12 | 3 | HP:0000977 | |
| HumanPheno | Abnormal forearm morphology | 1.32e-04 | 239 | 12 | 5 | HP:0002973 | |
| HumanPheno | Genital hernia | 1.41e-04 | 8 | 12 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 1.41e-04 | 8 | 12 | 2 | HP:0025019 | |
| HumanPheno | Blepharochalasis | 1.41e-04 | 8 | 12 | 2 | HP:0010749 | |
| HumanPheno | Platyspondyly | 1.42e-04 | 124 | 12 | 4 | HP:0000926 | |
| HumanPheno | Joint contracture | 1.44e-04 | 843 | 12 | 8 | HP:0034392 | |
| HumanPheno | Lower-limb joint contracture | 1.45e-04 | 403 | 12 | 6 | HP:0005750 | |
| HumanPheno | Arthritis | 1.66e-04 | 251 | 12 | 5 | HP:0001369 | |
| HumanPheno | Abnormal tendon morphology | 1.90e-04 | 875 | 12 | 8 | HP:0100261 | |
| HumanPheno | Abnormal anterior fontanelle morphology | 2.04e-04 | 136 | 12 | 4 | HP:0000236 | |
| HumanPheno | Abnormal limb epiphysis morphology | 2.16e-04 | 138 | 12 | 4 | HP:0006505 | |
| HumanPheno | Premature osteoarthritis | 2.27e-04 | 10 | 12 | 2 | HP:0003088 | |
| HumanPheno | Joint laxity | 2.45e-04 | 55 | 12 | 3 | HP:0001388 | |
| HumanPheno | Abnormality of the elbow | 2.88e-04 | 282 | 12 | 5 | HP:0009811 | |
| HumanPheno | Rectal prolapse | 3.02e-04 | 59 | 12 | 3 | HP:0002035 | |
| HumanPheno | Arterial dissection | 3.31e-04 | 12 | 12 | 2 | HP:0005294 | |
| HumanPheno | Dermatochalasis | 3.31e-04 | 12 | 12 | 2 | HP:0010750 | |
| HumanPheno | Arteriovenous fistula | 3.31e-04 | 12 | 12 | 2 | HP:0004947 | |
| HumanPheno | Midface retrusion | 3.34e-04 | 291 | 12 | 5 | HP:0011800 | |
| HumanPheno | Limb joint contracture | 3.36e-04 | 469 | 12 | 6 | HP:0003121 | |
| HumanPheno | Constipation | 3.49e-04 | 472 | 12 | 6 | HP:0002019 | |
| HumanPheno | Abnormal uterine cervix morphology | 3.91e-04 | 13 | 12 | 2 | HP:0012888 | |
| HumanPheno | Abnormality of upper limb joint | 3.97e-04 | 705 | 12 | 7 | HP:0009810 | |
| HumanPheno | Abnormal upper limb bone morphology | 4.00e-04 | 484 | 12 | 6 | HP:0040070 | |
| HumanPheno | Abnormality of the knee | 4.33e-04 | 491 | 12 | 6 | HP:0002815 | |
| HumanPheno | Recurrent joint dislocation | 4.56e-04 | 14 | 12 | 2 | HP:0031869 | |
| HumanPheno | Tricuspid valve prolapse | 4.56e-04 | 14 | 12 | 2 | HP:0001704 | |
| HumanPheno | Soft, doughy skin | 4.56e-04 | 14 | 12 | 2 | HP:0001027 | |
| HumanPheno | Bowing of the long bones | 4.91e-04 | 316 | 12 | 5 | HP:0006487 | |
| HumanPheno | Aortic root aneurysm | 5.00e-04 | 70 | 12 | 3 | HP:0002616 | |
| HumanPheno | Anomaly of the limb diaphyses | 5.35e-04 | 322 | 12 | 5 | HP:0006504 | |
| HumanPheno | Large fontanelles | 5.48e-04 | 176 | 12 | 4 | HP:0000239 | |
| HumanPheno | Abnormal stomach morphology | 5.49e-04 | 742 | 12 | 7 | HP:0002577 | |
| HumanPheno | Abnormal cornea morphology | 5.58e-04 | 744 | 12 | 7 | HP:0000481 | |
| HumanPheno | Gastroesophageal reflux | 5.75e-04 | 517 | 12 | 6 | HP:0002020 | |
| HumanPheno | Hypoplastic ischia | 5.99e-04 | 16 | 12 | 2 | HP:0003175 | |
| HumanPheno | Small nail | 6.36e-04 | 183 | 12 | 4 | HP:0001792 | |
| HumanPheno | Premature rupture of membranes | 6.78e-04 | 17 | 12 | 2 | HP:0001788 | |
| HumanPheno | Knee pain | 6.78e-04 | 17 | 12 | 2 | HP:0030839 | |
| HumanPheno | Abnormal diaphysis morphology | 7.17e-04 | 343 | 12 | 5 | HP:0000940 | |
| HumanPheno | Camptodactyly | 7.47e-04 | 346 | 12 | 5 | HP:0012385 | |
| HumanPheno | Flared metaphysis | 7.48e-04 | 191 | 12 | 4 | HP:0003015 | |
| HumanPheno | Abnormal finger morphology | COL5A2 COL6A3 COL7A1 COL11A1 COL11A2 ABL1 SFTPA2 NSUN2 COL1A1 | 7.61e-04 | 1385 | 12 | 9 | HP:0001167 |
| HumanPheno | Abnormality of the joints of the lower limbs | 7.81e-04 | 547 | 12 | 6 | HP:0100239 | |
| HumanPheno | Aplastic/hypoplastic fingernail | 7.97e-04 | 82 | 12 | 3 | HP:0008384 | |
| HumanPheno | Abnormality of the temporomandibular joint | 8.51e-04 | 19 | 12 | 2 | HP:0010754 | |
| HumanPheno | Dilatation of the ascending aorta | 8.55e-04 | 84 | 12 | 3 | HP:0005111 | |
| HumanPheno | Congenital hip dislocation | 8.55e-04 | 84 | 12 | 3 | HP:0001374 | |
| HumanPheno | Abnormal eyelid morphology | CACNA1A COL5A2 COL18A1 COL9A3 COL11A1 COL11A2 ABL1 NSUN2 COL1A1 | 8.69e-04 | 1408 | 12 | 9 | HP:0000492 |
| HumanPheno | Abnormal femoral neck/head morphology | 9.07e-04 | 201 | 12 | 4 | HP:0003366 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 9.16e-04 | 86 | 12 | 3 | HP:0006499 | |
| HumanPheno | Flexion contracture of digit | 9.20e-04 | 362 | 12 | 5 | HP:0030044 | |
| HumanPheno | Abnormal knee morphology | 9.43e-04 | 364 | 12 | 5 | HP:0034669 | |
| HumanPheno | Shoulder dislocation | 9.44e-04 | 20 | 12 | 2 | HP:0003834 | |
| HumanPheno | Pes planus | 9.55e-04 | 365 | 12 | 5 | HP:0001763 | |
| HumanPheno | Anorectal anomaly | 9.92e-04 | 368 | 12 | 5 | HP:0012732 | |
| HumanPheno | Arthralgia | 1.01e-03 | 207 | 12 | 4 | HP:0002829 | |
| HumanPheno | Mild short stature | 1.04e-03 | 21 | 12 | 2 | HP:0003502 | |
| HumanPheno | Thin skin | 1.05e-03 | 90 | 12 | 3 | HP:0000963 | |
| HumanPheno | Abnormal fontanelle morphology | 1.09e-03 | 211 | 12 | 4 | HP:0011328 | |
| HumanPheno | Abnormal anterior eye segment morphology | CACNA1A COL5A2 COL18A1 COL7A1 COL9A3 COL11A1 COL11A2 NSUN2 COL1A1 | 1.10e-03 | 1450 | 12 | 9 | HP:0004328 |
| HumanPheno | Coxa valga | 1.11e-03 | 92 | 12 | 3 | HP:0002673 | |
| HumanPheno | Enlarged thorax | 1.19e-03 | 94 | 12 | 3 | HP:0100625 | |
| HumanPheno | Abnormal morphology of the radius | 1.21e-03 | 217 | 12 | 4 | HP:0002818 | |
| MousePheno | lethality, incomplete penetrance | 3.29e-05 | 258 | 21 | 5 | MP:0010831 | |
| MousePheno | abnormal long bone morphology | 3.84e-05 | 676 | 21 | 7 | MP:0003723 | |
| MousePheno | abnormal tendon collagen fibril morphology | 4.49e-05 | 7 | 21 | 2 | MP:0011643 | |
| MousePheno | abnormal cranium morphology | 1.24e-04 | 813 | 21 | 7 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 1.38e-04 | 827 | 21 | 7 | MP:0002116 | |
| MousePheno | lung inflammation | 1.49e-04 | 185 | 21 | 4 | MP:0001861 | |
| MousePheno | decreased grip strength | 1.51e-04 | 575 | 21 | 6 | MP:0010053 | |
| MousePheno | abnormal respiration | 1.87e-04 | 598 | 21 | 6 | MP:0001943 | |
| MousePheno | absent T cells | 1.93e-04 | 14 | 21 | 2 | MP:0008070 | |
| MousePheno | abnormal appendicular skeleton morphology | 2.28e-04 | 896 | 21 | 7 | MP:0009250 | |
| MousePheno | abnormal respiratory system physiology | 2.29e-04 | 897 | 21 | 7 | MP:0002133 | |
| MousePheno | decreased survivor rate | 2.65e-04 | 215 | 21 | 4 | MP:0008770 | |
| MousePheno | abnormal joint mobility | 2.88e-04 | 17 | 21 | 2 | MP:0008069 | |
| MousePheno | decreased length of long bones | 2.89e-04 | 409 | 21 | 5 | MP:0004686 | |
| MousePheno | respiratory system inflammation | 2.89e-04 | 220 | 21 | 4 | MP:0002405 | |
| MousePheno | abnormal heart ventricle size | 3.32e-04 | 228 | 21 | 4 | MP:0031543 | |
| MousePheno | kyphosis | 3.37e-04 | 229 | 21 | 4 | MP:0000160 | |
| MousePheno | osteoarthritis | 4.44e-04 | 21 | 21 | 2 | MP:0003560 | |
| MousePheno | abnormal maternal nurturing | 4.96e-04 | 105 | 21 | 3 | MP:0001386 | |
| MousePheno | abnormal physical strength | 5.27e-04 | 1027 | 21 | 7 | MP:0004262 | |
| MousePheno | craniofacial phenotype | 5.33e-04 | 1372 | 21 | 8 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 5.33e-04 | 1372 | 21 | 8 | MP:0000428 | |
| MousePheno | abnormal dermal layer morphology | 5.39e-04 | 108 | 21 | 3 | MP:0001243 | |
| MousePheno | decreased body length | 6.26e-04 | 484 | 21 | 5 | MP:0001258 | |
| MousePheno | abnormal lean body mass | 6.29e-04 | 749 | 21 | 6 | MP:0003959 | |
| MousePheno | abnormal maternal behavior | 6.47e-04 | 115 | 21 | 3 | MP:0008779 | |
| MousePheno | decreased skin tensile strength | 6.84e-04 | 26 | 21 | 2 | MP:0003089 | |
| MousePheno | postnatal lethality | 7.30e-04 | 1084 | 21 | 7 | MP:0002082 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 7.38e-04 | 27 | 21 | 2 | MP:0008438 | |
| MousePheno | abnormal axial skeleton morphology | 8.04e-04 | 1458 | 21 | 8 | MP:0002114 | |
| MousePheno | abnormal synovial joint morphology | 8.06e-04 | 124 | 21 | 3 | MP:0030804 | |
| MousePheno | neonatal lethality, incomplete penetrance | 9.09e-04 | 298 | 21 | 4 | MP:0011088 | |
| MousePheno | abnormal tendon morphology | 9.74e-04 | 31 | 21 | 2 | MP:0005503 | |
| MousePheno | abnormal skin tensile strength | 1.04e-03 | 32 | 21 | 2 | MP:0005275 | |
| MousePheno | abnormal body length | 1.12e-03 | 550 | 21 | 5 | MP:0001256 | |
| MousePheno | abnormal spine curvature | 1.16e-03 | 318 | 21 | 4 | MP:0004174 | |
| MousePheno | decreased cardiac output | 1.39e-03 | 37 | 21 | 2 | MP:0003393 | |
| MousePheno | increased susceptibility to Orthomyxoviridae infection | 1.39e-03 | 37 | 21 | 2 | MP:0020946 | |
| MousePheno | abnormal viscerocranium morphology | 1.56e-03 | 593 | 21 | 5 | MP:0005274 | |
| MousePheno | abnormal parental behavior | 1.68e-03 | 160 | 21 | 3 | MP:0002068 | |
| MousePheno | limbs/digits/tail phenotype | 1.77e-03 | 1258 | 21 | 7 | MP:0005371 | |
| Domain | Collagen | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 C1QTNF7 SFTPA2 SFTPD COL1A1 | 4.87e-24 | 85 | 28 | 13 | PF01391 |
| Domain | Collagen | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 C1QTNF7 SFTPA2 SFTPD COL1A1 | 4.87e-24 | 85 | 28 | 13 | IPR008160 |
| Domain | NC1_FIB | 1.32e-09 | 11 | 28 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 1.32e-09 | 11 | 28 | 4 | IPR000885 | |
| Domain | Fib_collagen_C | 1.32e-09 | 11 | 28 | 4 | PD002078 | |
| Domain | COLFI | 1.32e-09 | 11 | 28 | 4 | SM00038 | |
| Domain | COLFI | 1.32e-09 | 11 | 28 | 4 | PF01410 | |
| Domain | TSPN | 3.51e-08 | 23 | 28 | 4 | SM00210 | |
| Domain | Laminin_G | 1.62e-06 | 58 | 28 | 4 | IPR001791 | |
| Domain | - | 2.43e-06 | 18 | 28 | 3 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 2.43e-06 | 18 | 28 | 3 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 2.88e-06 | 19 | 28 | 3 | PS50279 | |
| Domain | Kunitz_BPTI | 2.88e-06 | 19 | 28 | 3 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 2.88e-06 | 19 | 28 | 3 | PS00280 | |
| Domain | - | 4.33e-06 | 74 | 28 | 4 | 3.40.50.410 | |
| Domain | Kunitz_BPTI | 5.24e-06 | 23 | 28 | 3 | IPR002223 | |
| Domain | VWA | 7.18e-06 | 84 | 28 | 4 | SM00327 | |
| Domain | VWF_A | 1.38e-05 | 99 | 28 | 4 | IPR002035 | |
| Domain | LamG | 3.84e-05 | 44 | 28 | 3 | SM00282 | |
| Domain | VWA | 7.93e-05 | 56 | 28 | 3 | PF00092 | |
| Domain | VWFA | 2.47e-04 | 82 | 28 | 3 | PS50234 | |
| Domain | ConA-like_dom | 3.02e-04 | 219 | 28 | 4 | IPR013320 | |
| Domain | KU | 3.27e-04 | 18 | 28 | 2 | SM00131 | |
| Domain | - | 4.05e-04 | 97 | 28 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 4.30e-04 | 99 | 28 | 3 | IPR016186 | |
| Domain | CTDL_fold | 5.40e-04 | 107 | 28 | 3 | IPR016187 | |
| Domain | VWC | 8.00e-04 | 28 | 28 | 2 | PF00093 | |
| Domain | VWFC_1 | 1.32e-03 | 36 | 28 | 2 | PS01208 | |
| Domain | VWC | 1.47e-03 | 38 | 28 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.47e-03 | 38 | 28 | 2 | PS50184 | |
| Domain | Laminin_G_2 | 1.63e-03 | 40 | 28 | 2 | PF02210 | |
| Domain | VWF_dom | 1.80e-03 | 42 | 28 | 2 | IPR001007 | |
| Domain | C-type_lectin_CS | 1.88e-03 | 43 | 28 | 2 | IPR018378 | |
| Domain | C_TYPE_LECTIN_1 | 6.37e-03 | 80 | 28 | 2 | PS00615 | |
| Domain | Lectin_C | 7.00e-03 | 84 | 28 | 2 | PF00059 | |
| Domain | CLECT | 7.00e-03 | 84 | 28 | 2 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 7.17e-03 | 85 | 28 | 2 | PS50041 | |
| Domain | C-type_lectin-like | 7.33e-03 | 86 | 28 | 2 | IPR001304 | |
| Domain | - | 8.88e-03 | 95 | 28 | 2 | 2.60.120.200 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.47e-20 | 41 | 23 | 10 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.24e-20 | 44 | 23 | 10 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.16e-18 | 61 | 23 | 10 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.18e-18 | 67 | 23 | 10 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.21e-17 | 76 | 23 | 10 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 7.19e-17 | 90 | 23 | 10 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL11A2 COL1A1 | 3.55e-16 | 64 | 23 | 9 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.55e-15 | 50 | 23 | 8 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.56e-14 | 61 | 23 | 8 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL11A2 COL1A1 | 5.26e-13 | 140 | 23 | 9 | M587 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 5.76e-13 | 46 | 23 | 7 | M198 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.65e-12 | 53 | 23 | 7 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.29e-12 | 258 | 23 | 10 | MM14572 |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.21e-12 | 66 | 23 | 7 | M18 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.47e-11 | 300 | 23 | 10 | M610 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.88e-11 | 74 | 23 | 7 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.11e-11 | 85 | 23 | 7 | M16441 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.14e-10 | 114 | 23 | 7 | MM14571 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.89e-09 | 76 | 23 | 6 | MM14867 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.05e-08 | 19 | 23 | 4 | MM15512 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.43e-07 | 30 | 23 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.43e-07 | 30 | 23 | 4 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.88e-07 | 32 | 23 | 4 | MM14924 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.06e-07 | 84 | 23 | 5 | M7098 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.24e-07 | 41 | 23 | 4 | M27778 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.17e-07 | 47 | 23 | 4 | MM14925 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.31e-06 | 59 | 23 | 4 | M27218 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.86e-06 | 67 | 23 | 4 | MM15345 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.25e-06 | 20 | 23 | 3 | MM15061 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.39e-06 | 76 | 23 | 4 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.46e-06 | 79 | 23 | 4 | M27643 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.46e-05 | 199 | 23 | 5 | M7253 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.08e-05 | 38 | 23 | 3 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.18e-05 | 42 | 23 | 3 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.31e-05 | 418 | 23 | 6 | MM15587 | |
| Pathway | PID_HNF3A_PATHWAY | 4.81e-05 | 44 | 23 | 3 | M285 | |
| Pathway | REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5 | 7.09e-05 | 8 | 23 | 2 | M27575 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.05e-04 | 57 | 23 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.10e-04 | 58 | 23 | 3 | M2049 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 1.14e-04 | 10 | 23 | 2 | M27573 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.41e-04 | 63 | 23 | 3 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.64e-04 | 532 | 23 | 6 | M27870 | |
| Pathway | WP_FOCAL_ADHESION | 2.18e-04 | 187 | 23 | 4 | MM15913 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 2.29e-04 | 14 | 23 | 2 | MM15011 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.64e-04 | 15 | 23 | 2 | M27161 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 3.01e-04 | 16 | 23 | 2 | M925 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 5.77e-04 | 22 | 23 | 2 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 5.77e-04 | 22 | 23 | 2 | MM15284 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 6.31e-04 | 23 | 23 | 2 | MM15279 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 6.88e-04 | 24 | 23 | 2 | M27803 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.70e-04 | 261 | 23 | 4 | MM15676 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 8.72e-04 | 27 | 23 | 2 | M27217 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.08e-03 | 30 | 23 | 2 | M27216 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.08e-03 | 30 | 23 | 2 | M27566 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.15e-03 | 31 | 23 | 2 | M27805 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.33e-03 | 302 | 23 | 4 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.76e-03 | 326 | 23 | 4 | MM15917 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.21e-03 | 43 | 23 | 2 | M39565 | |
| Pathway | PID_RB_1PATHWAY | 4.98e-03 | 65 | 23 | 2 | M279 | |
| Pathway | PID_TELOMERASE_PATHWAY | 5.28e-03 | 67 | 23 | 2 | M105 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 8.21e-03 | 502 | 23 | 4 | MM14537 | |
| Pubmed | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 SFTPA2 SFTPD COL1A1 | 6.04e-17 | 167 | 28 | 10 | 22159717 | |
| Pubmed | 9.98e-13 | 175 | 28 | 8 | 28071719 | ||
| Pubmed | 5.03e-12 | 6 | 28 | 4 | 21467034 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 5.03e-12 | 6 | 28 | 4 | 8563024 | |
| Pubmed | 1.22e-11 | 25 | 28 | 5 | 19180518 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.26e-11 | 135 | 28 | 7 | 28675934 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 2.35e-11 | 8 | 28 | 4 | 20059976 | |
| Pubmed | 3.04e-11 | 153 | 28 | 7 | 25037231 | ||
| Pubmed | 1.31e-10 | 39 | 28 | 5 | 33580754 | ||
| Pubmed | 2.81e-10 | 210 | 28 | 7 | 16537572 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 4.56e-10 | 15 | 28 | 4 | 9832566 | |
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 5.82e-09 | 27 | 28 | 4 | 12192060 | |
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 20301479 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 10722718 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 17876790 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 15922184 | ||
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 9.33e-09 | 6 | 28 | 3 | 22492985 | |
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 9164858 | ||
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 18816857 | ||
| Pubmed | 7.54e-08 | 50 | 28 | 4 | 23658023 | ||
| Pubmed | 1.69e-07 | 14 | 28 | 3 | 19542224 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.81e-07 | 62 | 28 | 4 | 28344315 | |
| Pubmed | 2.06e-07 | 64 | 28 | 4 | 22261194 | ||
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 2.11e-07 | 15 | 28 | 3 | 10579729 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19306436 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 33348901 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11780999 | ||
| Pubmed | Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. | 6.25e-07 | 2 | 28 | 2 | 9560475 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 37783295 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 2591970 | ||
| Pubmed | Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. | 6.25e-07 | 2 | 28 | 2 | 18040076 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 7704020 | ||
| Pubmed | [Pseudomonas aeruginosa and Surfactant-associated Proteins A and D]. | 6.25e-07 | 2 | 28 | 2 | 16406431 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 7560887 | ||
| Pubmed | Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. | 6.25e-07 | 2 | 28 | 2 | 12673280 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29781737 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 7721876 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25240749 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.82e-07 | 86 | 28 | 4 | 28327460 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.11e-06 | 97 | 28 | 4 | 27559042 | |
| Pubmed | Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. | 1.20e-06 | 26 | 28 | 3 | 21367821 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 12015304 | ||
| Pubmed | Surfactant proteins SP-A and SP-D: structure, function and receptors. | 1.87e-06 | 3 | 28 | 2 | 16213021 | |
| Pubmed | The role of polymorphisms of genes encoding collagen IX and XI in lumbar disc disease. | 1.87e-06 | 3 | 28 | 2 | 24636772 | |
| Pubmed | Macrophage-independent fungicidal action of the pulmonary collectins. | 1.87e-06 | 3 | 28 | 2 | 12857753 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15588319 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 12376353 | ||
| Pubmed | Surfactant protein A and surfactant protein D in health and disease. | 1.87e-06 | 3 | 28 | 2 | 9688929 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18983439 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 21601013 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 34009784 | ||
| Pubmed | Surfactant-associated protein A provides critical immunoprotection in neonatal mice. | 1.87e-06 | 3 | 28 | 2 | 17967856 | |
| Pubmed | Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help? | 1.87e-06 | 3 | 28 | 2 | 24960334 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18996902 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 26421960 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 26849628 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20301422 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8240330 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 10047533 | ||
| Pubmed | Role of surfactant proteins A and D in sepsis-induced acute kidney injury. | 1.87e-06 | 3 | 28 | 2 | 25255378 | |
| Pubmed | Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. | 1.87e-06 | 3 | 28 | 2 | 15280465 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8725251 | ||
| Pubmed | Change of surfactant protein D and A after renal ischemia reperfusion injury. | 1.87e-06 | 3 | 28 | 2 | 31877195 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 38375572 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15141750 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20413160 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15905537 | ||
| Pubmed | Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. | 1.87e-06 | 3 | 28 | 2 | 16456184 | |
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 1.87e-06 | 3 | 28 | 2 | 9582436 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 21199913 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 26511057 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 36553626 | ||
| Pubmed | 2.28e-06 | 32 | 28 | 3 | 23154389 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 12244199 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21527992 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 3.75e-06 | 4 | 28 | 2 | 17683922 | |
| Pubmed | Retinal degeneration mutation in Sftpa1tm1Kor/J and Sftpd -/- targeted mice. | 3.75e-06 | 4 | 28 | 2 | 29969487 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 10423401 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16861641 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 30388611 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 15145932 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 8806434 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 26603976 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23624467 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 27262512 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23183169 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 25987251 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 33974636 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28228557 | ||
| Pubmed | 3.87e-06 | 38 | 28 | 3 | 25572963 | ||
| Pubmed | 5.64e-06 | 146 | 28 | 4 | 27068509 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 9312071 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 16500946 | ||
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 6.24e-06 | 5 | 28 | 2 | 9659900 | |
| Pubmed | Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. | 6.24e-06 | 5 | 28 | 2 | 16133074 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 15365990 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 9169408 | ||
| Pubmed | The Hsp90 cochaperone p23 is essential for perinatal survival. | 9.36e-06 | 6 | 28 | 2 | 17000766 | |
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 9.36e-06 | 6 | 28 | 2 | 17029294 | |
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 9.36e-06 | 6 | 28 | 2 | 12883905 | |
| Interaction | MMP2 interactions | 1.21e-07 | 87 | 28 | 5 | int:MMP2 | |
| Interaction | LAIR2 interactions | 6.05e-07 | 49 | 28 | 4 | int:LAIR2 | |
| Interaction | COLGALT2 interactions | 2.15e-06 | 67 | 28 | 4 | int:COLGALT2 | |
| Interaction | COL18A1 interactions | 9.84e-06 | 98 | 28 | 4 | int:COL18A1 | |
| Interaction | THBS1 interactions | 2.74e-05 | 127 | 28 | 4 | int:THBS1 | |
| Interaction | SFTPA1 interactions | 5.19e-05 | 8 | 28 | 2 | int:SFTPA1 | |
| Interaction | SPARC interactions | 9.90e-05 | 65 | 28 | 3 | int:SPARC | |
| Interaction | LAMA1 interactions | 1.04e-04 | 66 | 28 | 3 | int:LAMA1 | |
| GeneFamily | Collagens | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 4.44e-21 | 46 | 23 | 10 | 490 |
| GeneFamily | Collectins | 6.92e-05 | 10 | 23 | 2 | 491 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.23e-03 | 41 | 23 | 2 | 1298 | |
| Coexpression | NABA_COLLAGENS | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.85e-22 | 43 | 28 | 10 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL23A1 COL5A2 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 7.57e-22 | 44 | 28 | 10 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 2.08e-15 | 270 | 28 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 2.55e-15 | 275 | 28 | 11 | M5884 |
| Coexpression | NABA_MATRISOME | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 C1QTNF7 SFTPA2 SFTPD COL1A1 | 3.44e-13 | 1008 | 28 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | COL23A1 COL5A2 COL18A1 PAPLN COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 C1QTNF7 SFTPA2 SFTPD COL1A1 | 4.37e-13 | 1026 | 28 | 14 | M5889 |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 3.52e-08 | 88 | 28 | 5 | M1167 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 6.70e-08 | 100 | 28 | 5 | MM514 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 6.33e-07 | 64 | 28 | 4 | M2572 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 8.58e-07 | 69 | 28 | 4 | M10165 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.14e-06 | 74 | 28 | 4 | M13547 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.10e-06 | 200 | 28 | 5 | M5930 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.61e-06 | 91 | 28 | 4 | M40180 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.92e-06 | 29 | 28 | 3 | MM17055 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.98e-06 | 35 | 28 | 3 | MM17054 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 7.86e-06 | 120 | 28 | 4 | M42505 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.05e-05 | 40 | 28 | 3 | M5887 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 1.61e-05 | 144 | 28 | 4 | M5942 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.61e-05 | 144 | 28 | 4 | M1484 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.72e-05 | 47 | 28 | 3 | M7585 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.80e-05 | 148 | 28 | 4 | MM1010 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | 2.96e-05 | 584 | 28 | 6 | M45668 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 3.41e-05 | 59 | 28 | 3 | M47989 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 3.96e-05 | 62 | 28 | 3 | M16774 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 4.56e-05 | 65 | 28 | 3 | M39309 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 4.98e-05 | 192 | 28 | 4 | M42501 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 5.22e-05 | 68 | 28 | 3 | M1373 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 5.22e-05 | 68 | 28 | 3 | M45669 | |
| Coexpression | GU_PDEF_TARGETS_UP | 5.94e-05 | 71 | 28 | 3 | M3955 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 6.02e-05 | 11 | 28 | 2 | M47997 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 6.20e-05 | 72 | 28 | 3 | MM1131 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 6.20e-05 | 72 | 28 | 3 | M9908 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 6.73e-05 | 74 | 28 | 3 | M4479 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 7.00e-05 | 75 | 28 | 3 | MM1084 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 8.18e-05 | 79 | 28 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 8.49e-05 | 80 | 28 | 3 | MM1285 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 8.81e-05 | 81 | 28 | 3 | M39253 | |
| Coexpression | ZHU_CMV_24_HR_DN | 9.82e-05 | 84 | 28 | 3 | M4065 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.34e-04 | 767 | 28 | 6 | M39209 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_LATE_UP | 1.55e-04 | 98 | 28 | 3 | M2026 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.67e-04 | 18 | 28 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.67e-04 | 18 | 28 | 2 | MM1241 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 1.90e-04 | 105 | 28 | 3 | M12602 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 2.24e-04 | 111 | 28 | 3 | M45685 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.62e-04 | 117 | 28 | 3 | M39300 | |
| Coexpression | ZHU_CMV_ALL_DN | 2.75e-04 | 119 | 28 | 3 | M14555 | |
| Coexpression | TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL | 3.25e-04 | 25 | 28 | 2 | M41674 | |
| Coexpression | SENESE_HDAC2_TARGETS_DN | 3.81e-04 | 133 | 28 | 3 | M6906 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 4.31e-04 | 337 | 28 | 4 | MM16606 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | 4.36e-04 | 955 | 28 | 6 | M45680 | |
| Coexpression | DORSEY_GAB2_TARGETS | 4.70e-04 | 30 | 28 | 2 | M14557 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 4.70e-04 | 30 | 28 | 2 | M47990 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL | 5.02e-04 | 31 | 28 | 2 | M45700 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.07e-04 | 352 | 28 | 4 | M17471 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 5.52e-04 | 151 | 28 | 3 | M8901 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 6.07e-04 | 156 | 28 | 3 | M40151 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 6.19e-04 | 157 | 28 | 3 | MM1099 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.30e-04 | 158 | 28 | 3 | MM17063 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.41e-04 | 35 | 28 | 2 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.78e-04 | 36 | 28 | 2 | MM1212 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 6.98e-04 | 681 | 28 | 5 | M39175 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN | 7.79e-04 | 170 | 28 | 3 | M8689 | |
| Coexpression | NABA_ECM_AFFILIATED | 7.79e-04 | 170 | 28 | 3 | M5880 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 8.11e-04 | 704 | 28 | 5 | M45672 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 8.79e-04 | 41 | 28 | 2 | M47988 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 9.03e-04 | 721 | 28 | 5 | M1999 | |
| Coexpression | BROWNE_HCMV_INFECTION_18HR_DN | 9.49e-04 | 182 | 28 | 3 | M6641 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 1.01e-03 | 44 | 28 | 2 | M18274 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 1.06e-03 | 45 | 28 | 2 | M1605 | |
| Coexpression | PGF_UP.V1_DN | 1.07e-03 | 190 | 28 | 3 | M2673 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 1.11e-03 | 46 | 28 | 2 | MM1187 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 1.12e-03 | 193 | 28 | 3 | M39321 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP | 1.21e-03 | 198 | 28 | 3 | M6361 | |
| Coexpression | GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN | 1.21e-03 | 198 | 28 | 3 | M7701 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 1.23e-03 | 199 | 28 | 3 | M8399 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP | 1.23e-03 | 199 | 28 | 3 | M5270 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.23e-03 | 199 | 28 | 3 | M6099 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP | 1.25e-03 | 200 | 28 | 3 | M3728 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP | 1.25e-03 | 200 | 28 | 3 | M8564 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN | 1.25e-03 | 200 | 28 | 3 | M9385 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN | 1.25e-03 | 200 | 28 | 3 | M390 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN | 1.25e-03 | 200 | 28 | 3 | M7058 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.25e-03 | 200 | 28 | 3 | M9687 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN | 1.25e-03 | 200 | 28 | 3 | M4027 | |
| Coexpression | GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN | 1.25e-03 | 200 | 28 | 3 | M5719 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP | 1.25e-03 | 200 | 28 | 3 | M3850 | |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 1.25e-03 | 200 | 28 | 3 | M8217 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN | 1.25e-03 | 200 | 28 | 3 | M8220 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN | 1.25e-03 | 200 | 28 | 3 | M5695 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 1.25e-03 | 49 | 28 | 2 | M2899 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 1.26e-03 | 201 | 28 | 3 | M1571 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.31e-03 | 50 | 28 | 2 | M1259 | |
| Coexpression | DESCARTES_FETAL_STOMACH_STROMAL_CELLS | 1.31e-03 | 50 | 28 | 2 | M40304 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 1.31e-03 | 50 | 28 | 2 | MM403 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 1.41e-03 | 52 | 28 | 2 | M19766 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.41e-03 | 52 | 28 | 2 | MM1118 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_DN | 1.52e-03 | 54 | 28 | 2 | M18630 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.59e-03 | 479 | 28 | 4 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.64e-03 | 483 | 28 | 4 | MM1082 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.75e-03 | 58 | 28 | 2 | M178 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL6A3 CHSY3 COL11A1 COL11A2 C1QTNF7 SFTPD ZFR2 TCEAL2 COL1A1 | 2.24e-06 | 992 | 27 | 9 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 5.14e-06 | 91 | 27 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.92e-06 | 406 | 27 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 1.35e-05 | 116 | 27 | 4 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.49e-05 | 281 | 27 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.49e-05 | 281 | 27 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 3.07e-05 | 143 | 27 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 4.12e-05 | 53 | 27 | 3 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.84e-05 | 336 | 27 | 5 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_500 | 6.92e-05 | 63 | 27 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k3 | |
| CoexpressionAtlas | BM Top 100 - cervix | 7.95e-05 | 66 | 27 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.19e-05 | 184 | 27 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 9.48e-05 | 70 | 27 | 3 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.03e-04 | 72 | 27 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 1.31e-04 | 78 | 27 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.39e-04 | 404 | 27 | 5 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 1.68e-04 | 976 | 27 | 7 | PCBC_ECTO_blastocyst_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 1.79e-04 | 986 | 27 | 7 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | 1.88e-04 | 994 | 27 | 7 | PCBC_EB_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 2.07e-04 | 91 | 27 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 2.35e-04 | 95 | 27 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.42e-04 | 244 | 27 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 2.57e-04 | 98 | 27 | 3 | Arv_EB-LF_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 2.62e-04 | 249 | 27 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_200 | 2.63e-04 | 19 | 27 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k1 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_100 | 2.65e-04 | 99 | 27 | 3 | JC_fibro_100 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.73e-04 | 100 | 27 | 3 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.73e-04 | 100 | 27 | 3 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 3.31e-04 | 487 | 27 | 5 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 3.37e-04 | 489 | 27 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.87e-04 | 276 | 27 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 3.94e-04 | 790 | 27 | 6 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 4.19e-04 | 799 | 27 | 6 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 4.31e-04 | 284 | 27 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 4.44e-04 | 118 | 27 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.66e-04 | 120 | 27 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.01e-04 | 123 | 27 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.17e-04 | 298 | 27 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 5.30e-04 | 300 | 27 | 4 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | 6.15e-04 | 1208 | 27 | 7 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.72e-04 | 136 | 27 | 3 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 6.86e-04 | 137 | 27 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.16e-04 | 139 | 27 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.98e-04 | 591 | 27 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2 | 8.42e-04 | 147 | 27 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2 | |
| CoexpressionAtlas | MESO-5 UCB CD34+Z_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.13e-03 | 163 | 27 | 3 | PCBC_ratio_MESO-5 UCB CD34+Z_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.14e-03 | 967 | 27 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.14e-03 | 967 | 27 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 1.14e-03 | 967 | 27 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 1.15e-03 | 968 | 27 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.17e-03 | 371 | 27 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 1.17e-03 | 972 | 27 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 1.18e-03 | 973 | 27 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_1000 | 1.18e-03 | 974 | 27 | 6 | PCBC_MESO-5_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 1.32e-03 | 994 | 27 | 6 | PCBC_ratio_EB_vs_SC_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | 1.45e-03 | 393 | 27 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.47e-03 | 395 | 27 | 4 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 1.63e-03 | 406 | 27 | 4 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.74e-03 | 413 | 27 | 4 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.90e-03 | 195 | 27 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-03 | 197 | 27 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.95e-03 | 197 | 27 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.99e-03 | 726 | 27 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.07e-03 | 201 | 27 | 3 | Arv_EB-LF_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.09e-03 | 734 | 27 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.15e-03 | 1094 | 27 | 6 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.47e-03 | 214 | 27 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.47e-03 | 214 | 27 | 3 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.51e-03 | 457 | 27 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_500 | 2.63e-03 | 60 | 27 | 2 | gudmap_developingGonad_e12.5_ovary_k4_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.69e-03 | 466 | 27 | 4 | GSM777050_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 2.80e-03 | 1153 | 27 | 6 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.88e-03 | 475 | 27 | 4 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 2.89e-03 | 791 | 27 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | 2.96e-03 | 1166 | 27 | 6 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 2.97e-03 | 479 | 27 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 2.99e-03 | 797 | 27 | 5 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 2.99e-03 | 64 | 27 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 2.99e-03 | 64 | 27 | 2 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 3.05e-03 | 801 | 27 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 3.08e-03 | 65 | 27 | 2 | BM Top 100 - myometrium | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 3.13e-03 | 486 | 27 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 3.18e-03 | 66 | 27 | 2 | BM Top 100 - endometrium | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_500 | 3.25e-03 | 491 | 27 | 4 | PCBC_MESO-5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.33e-03 | 238 | 27 | 3 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 3.36e-03 | 819 | 27 | 5 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 3.36e-03 | 819 | 27 | 5 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 3.37e-03 | 68 | 27 | 2 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | BM Top 100 - lymph nodes | 3.37e-03 | 68 | 27 | 2 | BM Top 100 - lymph nodes | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 3.37e-03 | 496 | 27 | 4 | Arv_EB-LF_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 3.42e-03 | 498 | 27 | 4 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 3.47e-03 | 69 | 27 | 2 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.49e-03 | 501 | 27 | 4 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 3.49e-03 | 501 | 27 | 4 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.49e-03 | 501 | 27 | 4 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 3.50e-03 | 827 | 27 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | BM Top 100 - ovary | 3.57e-03 | 70 | 27 | 2 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 3.57e-03 | 70 | 27 | 2 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 3.67e-03 | 71 | 27 | 2 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 3.67e-03 | 836 | 27 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-11 | 185 | 28 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-09 | 180 | 28 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-09 | 180 | 28 | 6 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-09 | 182 | 28 | 6 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-09 | 182 | 28 | 6 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-09 | 182 | 28 | 6 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-09 | 183 | 28 | 6 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-09 | 183 | 28 | 6 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-09 | 183 | 28 | 6 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-09 | 194 | 28 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-09 | 198 | 28 | 6 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.34e-09 | 198 | 28 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-09 | 198 | 28 | 6 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.34e-09 | 198 | 28 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-09 | 198 | 28 | 6 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-09 | 198 | 28 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-09 | 199 | 28 | 6 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-09 | 200 | 28 | 6 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-09 | 200 | 28 | 6 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-09 | 200 | 28 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.47e-08 | 157 | 28 | 5 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.61e-08 | 158 | 28 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.76e-08 | 159 | 28 | 5 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-08 | 169 | 28 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.68e-08 | 175 | 28 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-08 | 177 | 28 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-08 | 177 | 28 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.36e-08 | 178 | 28 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 9.09e-08 | 181 | 28 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.34e-08 | 182 | 28 | 5 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-08 | 182 | 28 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-08 | 183 | 28 | 5 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 9.60e-08 | 183 | 28 | 5 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-07 | 186 | 28 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.10e-07 | 188 | 28 | 5 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.10e-07 | 188 | 28 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 1.10e-07 | 188 | 28 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-07 | 189 | 28 | 5 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-07 | 189 | 28 | 5 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-07 | 190 | 28 | 5 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 191 | 28 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-07 | 191 | 28 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 191 | 28 | 5 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 191 | 28 | 5 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-07 | 191 | 28 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 191 | 28 | 5 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 191 | 28 | 5 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 191 | 28 | 5 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 191 | 28 | 5 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 191 | 28 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-07 | 192 | 28 | 5 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-07 | 192 | 28 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-07 | 192 | 28 | 5 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-07 | 192 | 28 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 192 | 28 | 5 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-07 | 192 | 28 | 5 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-07 | 192 | 28 | 5 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-07 | 193 | 28 | 5 | 47d189bac0ef4df2f5c6dd987e46aca85bd7e2af | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-07 | 193 | 28 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-07 | 193 | 28 | 5 | b637e1c47a98009e7d19a6daac78f888fd12748f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.27e-07 | 73 | 28 | 4 | 116259a036373bccaeb77fe3c675741a5ca81c52 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.28e-07 | 194 | 28 | 5 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-07 | 194 | 28 | 5 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-07 | 194 | 28 | 5 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-07 | 195 | 28 | 5 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-07 | 195 | 28 | 5 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-07 | 195 | 28 | 5 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-07 | 195 | 28 | 5 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-07 | 195 | 28 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-07 | 195 | 28 | 5 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-07 | 195 | 28 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-07 | 195 | 28 | 5 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-07 | 196 | 28 | 5 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-07 | 196 | 28 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 1.35e-07 | 196 | 28 | 5 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-07 | 196 | 28 | 5 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-07 | 196 | 28 | 5 | d5ed41fa111750e6b363c04cccc40a47dd774852 | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-07 | 196 | 28 | 5 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-07 | 196 | 28 | 5 | 760885dc608c82768fe0decd63ed9fda8315f453 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 197 | 28 | 5 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-07 | 197 | 28 | 5 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-07 | 197 | 28 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-07 | 197 | 28 | 5 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-07 | 197 | 28 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-07 | 198 | 28 | 5 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.42e-07 | 198 | 28 | 5 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-07 | 198 | 28 | 5 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 198 | 28 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-07 | 198 | 28 | 5 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 198 | 28 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-07 | 199 | 28 | 5 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.46e-07 | 199 | 28 | 5 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-07 | 199 | 28 | 5 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-07 | 199 | 28 | 5 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-07 | 199 | 28 | 5 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-07 | 199 | 28 | 5 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.46e-07 | 199 | 28 | 5 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-07 | 199 | 28 | 5 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-07 | 199 | 28 | 5 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-07 | 199 | 28 | 5 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| Computational | Adhesion molecules. | 1.00e-09 | 141 | 17 | 7 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.43e-07 | 50 | 17 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Spinal cord (neuro-development) genes. | 1.82e-04 | 360 | 17 | 5 | MODULE_12 | |
| Computational | ECM and collagens. | 3.59e-04 | 225 | 17 | 4 | MODULE_47 | |
| Computational | Neighborhood of CDH11 | 6.91e-04 | 25 | 17 | 2 | GNF2_CDH11 | |
| Computational | Genes in the cancer module 153. | 1.28e-03 | 34 | 17 | 2 | MODULE_153 | |
| Computational | Neighborhood of PTX3 | 1.44e-03 | 36 | 17 | 2 | GNF2_PTX3 | |
| Computational | Developmental processes. | 1.56e-03 | 333 | 17 | 4 | MODULE_220 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.76e-03 | 50 | 17 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes in the cancer module 287. | 2.76e-03 | 50 | 17 | 2 | MODULE_287 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.76e-03 | 50 | 17 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.76e-03 | 50 | 17 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.76e-03 | 50 | 17 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.76e-03 | 50 | 17 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Bone remodeling. | 3.21e-03 | 54 | 17 | 2 | MODULE_234 | |
| Computational | Genes in the cancer module 105. | 3.56e-03 | 200 | 17 | 3 | MODULE_105 | |
| Computational | Enzyme inhibitors (esp serine proteases). | 4.08e-03 | 61 | 17 | 2 | MODULE_164 | |
| Drug | GK-101 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.41e-19 | 36 | 28 | 9 | CID000161853 |
| Drug | Madecassol | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.64e-18 | 46 | 28 | 9 | CID000108062 |
| Drug | d-indobufen | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.71e-18 | 50 | 28 | 9 | CID000044562 |
| Drug | ridogrel | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.44e-18 | 52 | 28 | 9 | CID005362391 |
| Drug | NSC49633 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 6.55e-18 | 53 | 28 | 9 | CID000023340 |
| Drug | AC1LAKND | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 2.98e-17 | 62 | 28 | 9 | CID000470146 |
| Drug | hydroxylysine | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 SFTPD COL1A1 | 5.06e-17 | 109 | 28 | 10 | CID000001029 |
| Drug | BAPN | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.09e-16 | 71 | 28 | 9 | CID000001647 |
| Drug | malotilate | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.09e-16 | 71 | 28 | 9 | CID000004006 |
| Drug | AC1NMZ1B | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.82e-16 | 75 | 28 | 9 | CID005034185 |
| Drug | strontium ranelate | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 2.34e-16 | 77 | 28 | 9 | CID006918182 |
| Drug | halofuginone lactate | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.94e-16 | 85 | 28 | 9 | CID000062891 |
| Drug | 4-hydroxyproline | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.13e-15 | 91 | 28 | 9 | CID000000825 |
| Drug | ticlopidine | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.57e-15 | 103 | 28 | 9 | CID000005472 |
| Drug | AC1L1C2F | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 6.57e-15 | 110 | 28 | 9 | CID000001711 |
| Drug | PPACK | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 8.43e-15 | 113 | 28 | 9 | CID003036757 |
| Drug | AC1L9732 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 9.14e-15 | 114 | 28 | 9 | CID000439300 |
| Drug | Tranilast sodium | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 9.91e-15 | 115 | 28 | 9 | CID000005527 |
| Drug | foscarnet | COL23A1 CACNA1A COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.49e-14 | 190 | 28 | 10 | CID000003414 |
| Drug | Selara | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 2.14e-14 | 125 | 28 | 9 | CID000150310 |
| Drug | L-3,4-dehydroproline | 2.22e-14 | 73 | 28 | 8 | CID000094284 | |
| Drug | DMSe | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.53e-14 | 132 | 28 | 9 | CID000020796 |
| Drug | pirfenidone | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.31e-14 | 138 | 28 | 9 | CID000040632 |
| Drug | DL-penicillamine | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.67e-14 | 139 | 28 | 9 | CID000004727 |
| Drug | PCR 4099 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.67e-14 | 139 | 28 | 9 | CID000002806 |
| Drug | candesartan cilexetil | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 8.35e-14 | 145 | 28 | 9 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 2.30e-13 | 162 | 28 | 9 | CID000072363 |
| Drug | khellin | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.76e-13 | 171 | 28 | 9 | CID000003828 |
| Drug | AC1L1DD6 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.69e-13 | 179 | 28 | 9 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 9.32e-13 | 189 | 28 | 9 | CID000001413 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 SFTPD COL1A1 | 2.27e-12 | 314 | 28 | 10 | CID000447989 |
| Drug | AC1Q6PCP | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.47e-12 | 230 | 28 | 9 | CID000005267 |
| Drug | prostacyclin sodium salt | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.16e-11 | 250 | 28 | 9 | CID000000159 |
| Drug | hyaluronan | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.82e-11 | 263 | 28 | 9 | CID000024759 |
| Drug | chondroitin sulfate | COL23A1 COL18A1 COL6A3 COL7A1 CHSY3 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.39e-11 | 413 | 28 | 10 | CID000024766 |
| Drug | silibinin | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.73e-11 | 285 | 28 | 9 | CID000005213 |
| Drug | AC1L18QD | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.20e-10 | 325 | 28 | 9 | CID000000213 |
| Drug | losartan | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 4.56e-10 | 378 | 28 | 9 | CID000003961 |
| Drug | colchine | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 5.12e-10 | 383 | 28 | 9 | CID000002833 |
| Drug | Y-27632 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.87e-09 | 444 | 28 | 9 | CID000005711 |
| Drug | AC1L1KMJ | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.43e-09 | 476 | 28 | 9 | CID000030956 |
| Drug | 1h00 | 7.06e-09 | 56 | 28 | 5 | CID000445950 | |
| Drug | aspirin | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 1.47e-08 | 563 | 28 | 9 | CID000002244 |
| Drug | LMWH | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 6.00e-08 | 663 | 28 | 9 | CID000000772 |
| Drug | isodesmosine | 7.30e-08 | 33 | 28 | 4 | CID000013811 | |
| Drug | dermatan sulfate | 2.40e-07 | 220 | 28 | 6 | CID000032756 | |
| Drug | NC-4 | 2.40e-07 | 44 | 28 | 4 | CID006420119 | |
| Drug | LS-63783 | COL23A1 COL18A1 COL6A3 COL7A1 COL9A3 COL11A1 COL22A1 COL11A2 COL1A1 | 3.08e-07 | 804 | 28 | 9 | CID000000231 |
| Drug | desmosine | 5.14e-07 | 53 | 28 | 4 | CID000025435 | |
| Drug | Paclitaxel | 1.71e-06 | 720 | 28 | 8 | ctd:D017239 | |
| Drug | 351A | 1.87e-06 | 20 | 28 | 3 | CID000122144 | |
| Drug | pyridinoline | 6.36e-06 | 99 | 28 | 4 | CID000105068 | |
| Drug | PD123177 | 1.99e-05 | 43 | 28 | 3 | CID000114899 | |
| Drug | BPAT-143 | 2.18e-05 | 6 | 28 | 2 | CID000146249 | |
| Drug | 1zd2 | 2.28e-05 | 45 | 28 | 3 | CID004149241 | |
| Drug | AC1OLRFQ | 4.07e-05 | 8 | 28 | 2 | CID007408461 | |
| Drug | sodium chloride | 6.56e-05 | 865 | 28 | 7 | CID000000206 | |
| Drug | 4-aminoazobenzene | 7.24e-05 | 66 | 28 | 3 | CID000006051 | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 3610_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 2787_UP | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 6818_UP | |
| Drug | 1-Methyl-3-isobutylxanthine | 1.35e-04 | 414 | 28 | 5 | ctd:D015056 | |
| Drug | phenytoin | 1.42e-04 | 219 | 28 | 4 | CID000001775 | |
| Drug | panobinostat | 1.46e-04 | 1333 | 28 | 8 | ctd:C496932 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 1.82e-04 | 90 | 28 | 3 | CID015942693 | |
| Drug | AC1L9HPX | 1.94e-04 | 92 | 28 | 3 | CID000445279 | |
| Drug | AGN-1133 | 2.01e-04 | 93 | 28 | 3 | CID000015178 | |
| Drug | mitomycin C | 2.05e-04 | 241 | 28 | 4 | CID000005746 | |
| Drug | arabinopyranose | 2.78e-04 | 261 | 28 | 4 | CID000000229 | |
| Drug | SD-208 | 3.63e-04 | 23 | 28 | 2 | CID010316032 | |
| Drug | B-Ms | 3.66e-04 | 114 | 28 | 3 | CID000445091 | |
| Drug | 1-2q | 4.09e-04 | 289 | 28 | 4 | CID000011820 | |
| Drug | NSC24559 | 4.46e-04 | 122 | 28 | 3 | CID000029051 | |
| Drug | AC1NRA8W | 5.80e-04 | 29 | 28 | 2 | CID005287760 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.84e-07 | 53 | 28 | 4 | C4707243 | |
| Disease | Disproportionate short stature | 8.37e-07 | 77 | 28 | 4 | C0878659 | |
| Disease | Fibrochondrogenesis | 8.68e-07 | 2 | 28 | 2 | C0265282 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 8.68e-07 | 2 | 28 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.60e-06 | 3 | 28 | 2 | C0220679 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.60e-06 | 3 | 28 | 2 | C4552122 | |
| Disease | Lumbar disc disease | 8.67e-06 | 5 | 28 | 2 | C0221775 | |
| Disease | Stickler syndrome, type 1 | 8.67e-06 | 5 | 28 | 2 | C2020284 | |
| Disease | Stickler syndrome | 8.67e-06 | 5 | 28 | 2 | cv:C0265253 | |
| Disease | Intervertebral disc disorder | 8.67e-06 | 5 | 28 | 2 | cv:C0158252 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 8.67e-06 | 5 | 28 | 2 | 603932 | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 1.30e-05 | 6 | 28 | 2 | DOID:12716 (biomarker_via_orthology) | |
| Disease | Intervertebral disc disorder | 1.30e-05 | 6 | 28 | 2 | C0158252 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.82e-05 | 7 | 28 | 2 | C1846545 | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 1.82e-05 | 7 | 28 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | Bleeding tendency | 1.82e-05 | 7 | 28 | 2 | C1458140 | |
| Disease | Ehlers-Danlos syndrome | 2.42e-05 | 8 | 28 | 2 | cv:C0013720 | |
| Disease | Cleft Palate | 6.21e-05 | 81 | 28 | 3 | C0008925 | |
| Disease | Connective Tissue Diseases | 6.73e-05 | 13 | 28 | 2 | C0009782 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 7.85e-05 | 14 | 28 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | Blood Coagulation Disorders | 1.03e-04 | 16 | 28 | 2 | C0005779 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.47e-04 | 19 | 28 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Abortion, Tubal | 1.50e-04 | 109 | 28 | 3 | C0000822 | |
| Disease | Early Pregnancy Loss | 1.50e-04 | 109 | 28 | 3 | C3830362 | |
| Disease | Miscarriage | 1.50e-04 | 109 | 28 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 1.50e-04 | 109 | 28 | 3 | C0000786 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.63e-04 | 20 | 28 | 2 | C0026760 | |
| Disease | Tinnitus | 2.53e-04 | 130 | 28 | 3 | HP_0000360 | |
| Disease | Heart valve disease | 2.78e-04 | 26 | 28 | 2 | C0018824 | |
| Disease | lung disease (biomarker_via_orthology) | 5.07e-04 | 35 | 28 | 2 | DOID:850 (biomarker_via_orthology) | |
| Disease | cervical cancer | 6.62e-04 | 40 | 28 | 2 | MONDO_0002974 | |
| Disease | Microcalcification | 7.30e-04 | 42 | 28 | 2 | C0521174 | |
| Disease | Calcinosis | 7.30e-04 | 42 | 28 | 2 | C0006663 | |
| Disease | Tumoral calcinosis | 7.30e-04 | 42 | 28 | 2 | C0263628 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 8.38e-04 | 45 | 28 | 2 | DOID:5199 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEGEGPDGGERRRRH | 991 | O00555 | |
| GEKGERGRAGELGEA | 346 | Q14050 | |
| PEDAEDGAEGGGKRG | 16 | Q08J23 | |
| EGGGGGLKREERGRD | 101 | P31275 | |
| GDRGEVGQIGPRGED | 796 | P12107 | |
| DRSERGEKGERGVPG | 491 | Q86Y22 | |
| GDRGSRGEKGDPGKD | 1096 | P39060 | |
| GEDGERGDDGEIGPR | 586 | P13942 | |
| GMDDDRGPRRGGADD | 1041 | Q14152 | |
| ELLRGGDGGERDEDG | 6 | Q8N8J7 | |
| RGDKGPRGEKGERGD | 2136 | P12111 | |
| NRGPRGETGDDGRDG | 2286 | P12111 | |
| GQPERRGAGEEEGRD | 626 | P00519 | |
| PRGDKGDHGDRGDRG | 1126 | P05997 | |
| ERGEKGTRGEKGERG | 591 | Q8NFW1 | |
| AGGERERRGAGDQPE | 126 | A6NNE9 | |
| VGEAGRPGERGERGE | 2051 | Q02388 | |
| RPGERGERGEKGERG | 2056 | Q02388 | |
| GERGEKGERGEQGRD | 2061 | Q02388 | |
| PGRDGRDGRKGEKGE | 61 | Q9BXJ2 | |
| LRKSPGGGREEEEGE | 281 | Q5VY09 | |
| VPGERGEKGEAGERG | 81 | Q8IWL1 | |
| KEEGRAGAGLGDGER | 286 | Q9BXP5 | |
| EEDGGAAGQRRDGRP | 136 | Q70JA7 | |
| GPRGDKGETGEQGDR | 1091 | P02452 | |
| RGPGEGEEGAGEKKR | 916 | Q9UPR6 | |
| GEEGAGEKKRGRRGG | 921 | Q9UPR6 | |
| DGRDGREGPRGEKGD | 51 | P35247 | |
| GDHRGERGDPRGDQG | 586 | O95428 | |
| EGKPERGGRAEGEGE | 91 | Q9H3H9 | |
| RGGRAEGEGEPDSER | 96 | Q9H3H9 | |
| DPEKGERLGGARRGD | 91 | P0C7X2 | |
| KEDGSGDRGDGPFRL | 171 | P13010 |